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The 130-kDa and 180-kDa replication proteins of Tomato mosaic virus (ToMV) covalently bind guanylate
and transfer it to the 50 end of RNA to form a cap. We found that guanylylation-competent ToMV
replication proteins are in membrane-bound, disulﬁde-linked complexes. Guanylylation-competent
replication proteins of Brome mosaic virus and Cucumber mosaic virus behaved similarly. To investigate
the roles of disulﬁde bonding in the functioning of ToMV replication proteins, each of the 19 cysteine
residues in the 130-kDa protein was replaced by a serine residue. Interestingly, three mutant proteins
(C179S, C186S and C581S) failed not only to be guanylylated, but also to bind to the replication
template and membranes. These mutants could trans-complement viral RNA replication. Considering
that ToMV replication proteins recognize the replication templates, bind membranes, and are
guanylylated in the cytoplasm that provides a reducing condition, we discuss the roles of cysteine
residues and disulﬁde bonds in ToMV RNA replication.
& 2012 Elsevier Inc. All rights reserved.Introduction
Many animal viruses of medical and veterinary importance and
most plant viruses are positive-strand RNA viruses. These viruses
have single-stranded, messenger-sense RNA genomes in virions.
After invasion of virions into host cells, their genomic RNAs are
released from virions into the cytoplasm and translated to produce
proteins that function in RNA replication. These replication proteins
selectively recruit their genomic RNAs onto host intracellular mem-
branes, and then synthesize complementary (negative-strand) RNAs.
Progeny genomic RNAs (and for some viruses, subgenomic RNAs) are
synthesized via the negative-strand RNAs. The negative-strand RNA
is sequestered in replication protein-containing, membrane-bound
complexes that are called ‘‘replication complexes’’ (Ahlquist, 2006;
den Boon and Ahlquist, 2010; den Boon et al., 2010).
The alphavirus-like superfamily includes animal viruses such
as Hepatitis E virus and Semliki forest virus, and many plant viruses
including Tobacco mosaic virus (TMV), Brome mosaic virus (BMV),
and Cucumber mosaic virus (CMV) (Scholthof et al., 2011; van der
Heijden and Bol, 2002). Their genomic RNAs have the 50-cap and
encode replication proteins that contain methyltransferase-like,
helicase-like, and polymerase-like domains and direct 50-capping
and viral RNA synthesis (van der Heijden and Bol, 2002). The genusll rights reserved.
).
ch, Madison, WI 53715, USA.Tobamovirus includes TMV and Tomato mosaic virus (ToMV), and
their genomic RNAs encode a replication protein of approximately
130 kDa (130K protein) and its read-through product of 180 kDa
(180K protein), a cell-to-cell movement protein, and a coat protein
(Ishikawa and Okada, 2004) (Fig. 1A). The 130K protein contains a
methyltransferase domain in its N-terminal region and transfers a
methyl group from S-adenosyl methionine (AdoMet) to the N7
position of GTP, forms a covalent complex with m7GMP (Merits
et al., 1999), and transfers the m7GMP moiety to 50-diphosphate
terminus of nascent progeny RNA to generate the 50-cap structure
(m7GpppGUAUU–) (Nishikiori et al., 2011). The 130K protein also
contains a helicase domain in its C-terminal region; and hydrolyzes
ribonucleoside triphosphates and unwinds double-stranded RNA
through hydrolysis of ATP (Goregaoker and Culver, 2003; Nishikiori
et al., 2012; Xiang et al., 2012). The helicase domain-containing
polypeptides interact with themselves in yeast and in vitro
(Goregaoker and Culver, 2003; Goregaoker et al., 2001). The 180K
protein contains a polymerase-like domain in its C-terminal read-
through region, and shows RNA-dependent RNA polymerase (RdRp)
activity (Nishikiori et al., 2006). Tobamovirus replication proteins
are multifunctional and serves in the process of RNA replication, as
well as in suppression of RNA silencing and other host defenses
(Ishibashi et al., 2010). A fraction of the tobamovirus replication
proteins co-translationally binds to the genomic RNA to form a
ribonucleoprotein complex, named the pre-membrane-targeting
complex (PMTC), which is targeted to membrane surfaces to form
the replication complex (Komoda et al., 2007). Another fraction of
tobamovirus replication proteins stays in the cytosol and binds
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Fig. 1. Guanylylation-competent ToMV replication proteins are contained in membrane-bound, SDS-resistant, DTT-sensitive, high-molecular-weight complexes.
(A) Schematic representation of ToMV and ToMV-180FS-GFP RNAs. (B) Effect of DTT treatment on the electrophoretic mobility of guanylylated ToMV replication proteins.
Extracts of ToMV-180FS-GFP-infected and evacuolated tobacco BY-2 protoplasts [iBYL (Nishikiori et al., 2006)] were subjected to centrifugation at 15,000 g to obtain
supernatant (S15: ‘‘S’’ in the ﬁgure) and pellet (P15: ‘‘P’’ in the ﬁgure) fractions. iBYL S15 and P15 fractions were incubated with [a-32P]GTP and AdoMet at 25 1C for 30 min,
and analyzed by non-reducing and reducing 3–8% SDS-PAGE and autoradiography. The asterisk represents a guanylylated putative capping enzyme of the host. The
positions of marker proteins are shown on the left with molecular masses. (C) Effect of DTT treatment on the electrophoretic mobility of ToMV replication proteins.
Aliquots of the iBYL S15 and P15 fractions were subjected to non-reducing and reducing 3–8% SDS-PAGE, followed by immunoblotting with antibodies against ToMV
replication proteins. The bracket indicates the disulﬁde-linked replication protein complexes. (D) Effect of DTT treatment on the electrophoretic mobility of cellular
proteins. Cellular proteins were detected by Coomassie brilliant blue staining of the blotted membranes. (E) Analysis of the guanylylated proteins in the disulﬁde-linked,
high-molecular-weight complexes. iBYL P15 fraction was incubated with [a-32P]GTP and AdoMet at 25 1C for 30 min, and subjected to non-reducing 3–8% SDS-PAGE (left
panel). 32P-labeled proteins were recovered from the gel region boxed by the dotted line, treated with 100 mM DTT, and then subjected to reducing SDS-PAGE (right
panel).
M. Nishikiori et al. / Virology 434 (2012) 118–128 119small RNA duplexes to suppress RNA silencing (Hagiwara-Komoda
et al., 2008; Ishibashi et al., 2011; Kurihara et al., 2007). The
functional differentiation occurs during and/or immediately after
translation by as yet unknown mechanisms (Komoda et al., 2007).
Replication of positive-strand RNA viruses depends not only on
viral replication proteins but also on host factors. To date, hundreds
of host factors involved in RNA replication of positive-strand RNA
viruses have been identiﬁed (Krishnan et al., 2008; Kushner et al.,
2003; Panavas et al., 2005; Sessions et al., 2009), and for several
factors, the functions in viral RNA replication have been revealed
(Nagy and Pogany, 2011). However, for the rest of the factors,
detailed analyses are under way. Previously, we showed that a host
transmembrane protein, TOM1, and a small GTP-binding protein,
ARL8, are necessary for tobamovirus RNA replication (Nishikiori et al.,
2011; Yamanaka et al., 2000). TOM1, ARL8, and the helicase-domain
polypeptide of tobamovirus replication proteins interact with each
other in yeast, and ARL8 is associated with TOM1 and ToMV
replication proteins that are active in RNA synthesis in infected plant
cells (Nishikiori et al., 2011, 2012; Yamanaka et al., 2000). In yeast,
the 130K protein acquires the RNA 50-capping-related functionswhen it is co-expressed with TOM1 and ARL8 (Nishikiori et al.,
2011). Thus, TOM1 and ARL8 play crucial roles in the activation of
replication-related functions of tobamovirus replication proteins on
membranes and are likely to be components of tobamovirus replica-
tion complex.
In this study, we found that guanylylation-competent ToMV
replication proteins are in membrane-bound, disulﬁde-linked
complexes. We further analyzed the phenotype of ToMV mutants
which encode the replication proteins with each of the cysteine
residues replaced by a serine residue to investigate the roles of
disulﬁde bonding in the functioning of ToMV replication proteins.Results
Guanylylation-competent ToMV replication proteins are in disulﬁde-
linked complexes
In previous biochemical analyses of the replication of tobamovirus
and other (þ)RNA viruses, reducing agents (e.g., b-mercaptoethanol
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Fig. 2. Properties of the DTT-sensitive ToMV replication protein complexes. (A)
Schematic representation of the experimental procedure. Proteins in the iBYL P15
fraction were solubilized with 1% LPC and fractionated by 10–50% (wt/wt) sucrose
gradient centrifugation in the presence (2 mM) ((B), (D), (F), and (H)) or absence ((C),
(E), (G), and (I)) of DTT. The gradient was manually fractionated into eight fractions
(numbered 1–8, from top to bottom of a gradient). 80S ribosomes were fractionated to
the fraction 3 (Nishikiori et al., 2006). ((B)–(E)) Sucrose gradient sedimentation analysis
of guanylylatable ToMV replication proteins. Aliquots of the eight fractions were
incubated with [a-32P]GTP and AdoMet, and analyzed by reducing ((B) and (C)) or non-
reducing ((D) and (E)) SDS-PAGE. ((F)–(I)) Sucrose gradient sedimentation analysis of
ToMV replication proteins. Aliquots of the eight fractions were subjected to reducing
((F) and (G)) or non-reducing ((H) and (I)) SDS-PAGE, followed by immunoblotting
with antibodies against ToMV replication proteins.
M. Nishikiori et al. / Virology 434 (2012) 118–128120and dithiothreitol [DTT]) were added to reaction mixtures to mimic
the redox state of the cytoplasm where RNA replication takes place
(Merits et al., 1999; Nishikiori et al., 2006; Osman and Buck, 1996,
1997; Watanabe et al., 1999). We accidentally performed an in vitro
guanylylation reaction with ToMV replication proteins prepared in
the absence of reducing agents, and found that guanylylated replica-
tion proteins migrated very slowly in non-reducing sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).
To conﬁrm this observation, we prepared extracts of ToMV-
180FS-GFP-infected (Fig. 1A), evacuolated tobacco BY-2 protoplasts
[iBYL, (Nishikiori et al., 2006, 2011)] without adding reducing
agents, and fractionated them by centrifugation at 15,000 g into
supernatant (S15) and membrane-rich pellet (P15) fractions. Each
fraction was incubated with [a-32P]GTP and AdoMet, and
32P-labeled proteins were analyzed by SDS-PAGE. When the P15
sample for SDS-PAGE was treated with DTT, bands were detected at
positions expected from their molecular masses of the ToMV 130K
and FLAG-StrepII-tagged 180K (180K-FS) proteins (130 kDa and
180 kDa, respectively) (Fig. 1B, left panel). In the S15 sample, 32P-
labeled replication proteins were not detected. Instead, a cellular
protein of about 70 kDa was detected (Fig. 1B, left panel). This band
may represent the cellular capping enzyme that also forms a covalent
complex with guanylate (Shuman, 2002).
The protein samples were next analyzed by SDS-PAGE without
DTT treatment. Denaturation of proteins (e.g., with SDS) in the
absence of reducing agents often cause the formation of unexpected
disulﬁde bonds. Therefore, to prevent post-denaturation formation of
disulﬁde bonds, the samples were treated with N-ethylmaleimide,
which blocks free sulfhydryl groups, followed by addition of 2% SDS
and incubation at 40 1C for 10 min. In the P15 sample, 32P-labeled
bands were not detected at positions expected for 130-kDa and
180-kDa proteins, but rather near the origin of electrophoresis
(Fig. 1B, right panel). A band was also detected near the origin of
electrophoresis even when samples were heated to 100 1C or treated
with 10% trichloroacetic acid or 4% SDS. When 32P-labeled proteins
recovered from the uppermost part of the non-reducing gel were
treated with DTT followed by separation using SDS-PAGE, bands
appeared at positions expected for 130-kDa and 180-kDa proteins
(Fig. 1E). In the S15 fraction that was not treated with DTT, the 130K
and 180K-FS proteins showed a similar separation pattern on
immunoblots as found for the DTT-treated S15 sample (Fig. 1C). In
the P15 fraction that was not treated with DTT, slowly migrating
smear bands of 130K and/or 180K-FS proteins (Fig. 1C, right panel,
indicated by a bracket), which disappeared when the sample was
treated with DTT, were detected on immunoblots (Fig. 1C, left panel).
Note that DTT treatment did not alter the migration pattern of a
putative cellular capping enzyme (the 32P-labeled protein of about
70 kDa) (Fig. 1B) and most other cellular proteins (Fig. 1D). These
results suggest that a minor fraction of membrane-bound ToMV
replication proteins exists in disulﬁde-linked complexes, and that
guanylylation-competent replication proteins exist in the complexes.
Effects of reduction on the guanylylation competence of ToMV
replication proteins
To clarify whether reduction of disulﬁde bonds decreases the
guanylylation activity of ToMV replication proteins or dissociates
the complexes, iBYL membrane proteins were solubilized by a
detergent (lysophosphatidylcholine [LPC]), fractionated by sucrose
gradient centrifugation in the presence or absence of DTT, and then
assayed for guanylylation activity. Solubilization by LPC did not
signiﬁcantly affect the guanylylation activity of ToMV replication
proteins. When DTT was not added during solubilization and
fractionation, guanylylation of ToMV replication proteins occurred
at a similar level to that observed for the sample prepared in the
presence of DTT (compare Fig. 2B with C). Guanylylation-competentreplication proteins were mainly recovered in fraction 2 (Fig. 2C).
When analyzed by SDS-PAGE in the presence and absence of DTT,
they migrated to the position expected from their molecular masses
and remained near the origin of electrophoresis, respectively (Fig. 2C
and E). Replication proteins that were not disulﬁde-linked and 80S
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Fig. 3. The ToMV 130K protein becomes guanylylation-competent when mixed
with membranes. (A) Schematic representation of ToMV and TL130FS RNAs. ((B)–(E))
The effect of addition of membranes on guanylylation activity. TL130FS RNA-
translated mdBYL reaction mixture was fractionated by centrifugation at
100,000 g to obtain S100 and P100 fractions (indicated by S and P in the ﬁgure,
respectively). 130K-FS was immunopuriﬁed from the S100 and P100 fractions with
anti-FLAG antibody, and the puriﬁed proteins were incubated with or without
membranes derived from BYL at 15 1C for 1 h (Komoda et al., 2007). Each mixture
was subjected to protein guanylylation assay ((B) and (C)) and immunoblotting ((D)
and (E)). SDS-PAGE was performed under reducing ((B) and (D)) or non-reducing ((C)
and (E)) conditions. The bracket indicates the intermolecularly disulﬁde-linked
replication protein complexes.
M. Nishikiori et al. / Virology 434 (2012) 118–128 121ribosomes were in fractions 1 and 3, respectively (Fig. 2G and I)
(Nishikiori et al., 2006).
When DTT was added during solubilization and fractionation, the
electrophoresis pattern of the replication proteins was not changed
by additional DTT treatment (100 mM) prior to SDS-PAGE (compare
Fig. 2B with D or Fig. 2F with H), indicating that the disulﬁde bonds
were fully reduced during solubilization and fractionation. Never-
theless, replication proteins maintained guanylylation competence,
and guanylylation-competent replication proteins were mainly
recovered in fraction 2 (Fig. 2B and D). These results suggest that
reduction of disulﬁde bonds neither affects the activity of ToMV
replication proteins to be guanylylated nor dissociates the replica-
tion protein-containing complexes. Note that exogenous template-
dependent RdRp activity was also fractionated in fraction 2 in this
condition (Nishikiori et al., 2006).
Guanylylation competence of ToMV replication proteins synthesized
by in vitro translation is increased by the addition of host membranes
ToMV replication proteins bind to the genomic RNA to form a pre-
membrane-targeting complex (PMTC), and then are targeted to
membranes to form the replication complex (Komoda et al., 2007).
To investigate whether ToMV replication proteins in the PMTC are
competent for guanylylation, we used an in vitro ToMV RNA transla-
tion and replication system using extracts of evacuolated tobacco
BY-2 protoplasts (BYL) (Komoda et al., 2007, 2004). BYL preparations
and the following translation and replication reactions were per-
formed without adding reducing agents (DTT was added to 2 mM
throughout in the original protocol). Omission of DTT had little effect
on the production of ToMV replication proteins and double-stranded
ToMV RNA (replicative form [RF]) (positive-strand RNA synthesis was
affected). Because the BYL translation mixture contained a high
concentration of GTP, the speciﬁc activity of [a-32P]GTP added to
the BYL-based mixtures upon guanylylation assays was lower than
expected. To circumvent this problem, we utilized TL130FS RNA,
which encodes C-terminally FLAG-StrepII-tagged 130K protein
(130K-FS: Fig. 3A). TL130FS RNA was translated in membrane-
depleted BYL (mdBYL), and the reaction mixture was fractionated
by centrifugation at 100,000 g into the supernatant (S100) and
pellet (P100) fractions. The P100 fraction contained core PMTC [a
PMTC-like complex that lacks the 180K protein (Komoda et al.,
2007)]. The 130K-FS protein was immunopuriﬁed from these frac-
tions with anti-FLAG antibody to remove GTP, incubated with
[a-32P]GTP and AdoMet, and 32P-labeled 130K-FS protein was ana-
lyzed by SDS-PAGE with or without DTT treatment (Fig. 3B and C,
‘‘membranes –’’ lanes). In addition, to examine the effect of adding
host membranes on guanylylation activity, 130K-FS proteins puriﬁed
from the S100 and P100 fractions were incubated with BYL mem-
branes and then subjected to the guanylylation assay (Fig. 3B and C,
‘‘membranes þ ’’). When samples were treated with DTT prior to SDS-
PAGE, 32P-labeled bands were detected at the position expected for a
130-kDa protein. This band was apparent in membrane-added 130K-
FS from the P100 fraction and more weakly in membrane-added
130K-FS from the S100 fraction (Fig. 3B, lanes 6 and 8). A very faint
signal was observed at the same position in 130K-FS from the P100
fraction without membranes, but not in that from the S100 fraction
without membranes (Fig. 3B, lanes 2 and 4). Immunoblot analysis
showed that these samples contained similar amounts of the 130K-FS
protein (Fig. 3D). Thus, the competence of 130K-FS for guanylylation
was enhanced by the addition of membranes. When SDS-PAGE
samples were not treated with DTT, 32P-labeled bands were not
detected at the position expected for a 130-kDa protein. Instead,
signals stronger than those observed for mock-translated samples
were detected near the origin of electrophoresis (Fig. 3C, compare
lanes 6 and 8 with lanes 5 and 7, respectively). DTT-sensitive, slowly
migrating smear bands of 130K-FS from the S100 and P100 fractionswere detected on immunoblots (Fig. 3E). These results suggest that
guanylylation competence of ToMV replication protein in either
soluble or PMTC fractions is enhanced via interactions with mem-
branes. Importantly, guanylylation-competent replication proteins
were contained in disulﬁde-linked complexes in both cases.
Guanylylation-competent ToMV 130K protein in yeast co-expressing
TOM1 and ARL8 is also in disulﬁde-linked complexes
Host transmembrane protein TOM1 and small GTP-binding
protein ARL8 are required for ToMV RNA replication. In the yeast
M. Nishikiori et al. / Virology 434 (2012) 118–128122Saccharomyces cerevisiae, which does not have TOM1 or ARL8
homologs, the ToMV 130K protein does not add a 50-cap on RNA
and it is not guanylylated if expressed alone. However, simultaneous
co-expression of TOM1 and ARL8 activates guanylylation and RNA
50-capping activities (Nishikiori et al., 2011). Co-expression of TOM1
alone slightly enhances guanylylation activity, but ARL8 alone does
not (Nishikiori et al., 2011). Co-expression of TOM1 with or without
ARL8 also enhances membrane association of the 130K protein
(Nishikiori et al., 2011). To examine whether guanylylation-
competent ToMV 130K protein puriﬁed from yeast is also in
disulﬁde-linked complexes, 130K-FS was expressed alone or with
TOM1 and/or ARL8 in yeast. 130K-FS was solubilized from mem-
brane fractions of yeast cell extracts, subjected to immunopuriﬁca-
tion with anti-FLAG antibody, incubated with [a-32P]GTP and
AdoMet, and analyzed by non-reducing SDS-PAGE. 32P-labeled
protein was detected near the origin of electrophoresis in samples
from yeast co-expressing either TOM1 alone or TOM1 plus ARL8ori
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Fig. 4. TOM1 and ARL8 facilitate formation of guanylylation-competent, DTT-sensi-
tive ToMV replication protein complexes in yeast. Membrane fractions prepared from
yeast expressing the indicated proteins and iBYL membranes from ToMV-180FS-GFP-
induced and uninduced BY-2 cells (indicated by ‘‘Plant’’ in the ﬁgure) were treated
with 1% LPC and subjected to immunopuriﬁcation with anti-FLAG antibody. The
protein samples were prepared so that the concentration of the replication proteins
was similar (samples for lanes 1 and 6 were prepared and analyzed in the same way
as for those for lanes 2 and 7, respectively). The protein samples were then subjected
to protein guanylylation assay ((A) and (B)) and immunoblotting using antibodies
against ToMV replication proteins ((C) and (D)). SDS-PAGE was performed under
reducing ((A) and (C)) or non-reducing ((B) and (D)) conditions.(Fig. 4B). A 130-kDa band was observed when the samples for SDS-
PAGE were treated with DTT (Fig. 4A). Immunoblot analysis showed
that the amount of disulﬁde-linked 130K-FS protein was increased
by the co-expression of TOM1, and more strongly by that of TOM1
and ARL8 (compare Fig. 4D with C). These results indicate that
TOM1 facilitates formation of guanylylation-competent ToMV 130K
protein that exists in the disulﬁde-linked complexes and that ARL8
enhances the effect of TOM1.
Effects of cysteine-to-serine substitutions in ToMV 130K protein on
membrane association and guanylylation competence
To gain further insight into how formation of disulﬁde-linked
complexes inﬂuence guanylylation competence in ToMV 130K pro-
tein, a series of ToMV mutants were constructed that encode the
130K protein in which each cysteine residue (–CH2–SH) was replaced
with a serine residue (–CH2–OH) (Fig. 5A). We translated mutant
ToMV RNAs in BYL (containing membranes), fractionated the reaction
mixture into the S15 (soluble) and P15 (membrane) fractions, and
examined amounts and disulﬁde-linking status of the replication
proteins by immunoblotting after SDS-PAGE under reducing and
non-reducing conditions (Fig. 5B to F). For C126S (2), C179S (3),
C186S (4), C225S (6), and C581S (11) mutants, the amount of
replication proteins in the P15 fraction was lower than that in the
S15 fraction (Fig. 5C and E). Slowly migrating signals were not (C179S
[3], C186S [4], and C581S [11]) or hardly (C126S [2] and C225S [6])
observed (Fig. 5D and F, indicated by brackets). For wild-type and the
other mutants, the amount of replication proteins in the P15 fraction
was higher than in the S15 fraction (Fig. 5C and E), and DTT-sensitive
signals with low electrophoretic mobility were observed in P15 and
more faintly in S15 (Fig. 5D and F, indicated by brackets).
Next, we added [a-32P]GTP and AdoMet to the P15 fractions
and 32P-labeled proteins were analyzed by SDS-PAGE (Fig. 5G and
H). As expected from the amount of replication proteins in the
P15 fractions, bands were not detected for C179S (3), C186S (4),
and C581S (11) mutants, and only faint signals were observed for
C126S (2) and C225S (6) mutants.
Last, we examined the activity of RNA synthesis by adding
[a-32P]CTP and other ribonucleoside triphosphates to the P15
fractions. For C179S (3), C186S (4), and C581S (11) mutants, RNA
replication was not detected (Fig. 5I). For C126S (2), C225S (6),
C282S (8), C837S (14), and C969S (18) mutants, low levels of RNA
synthesis were observed. Some mutants (e.g., C250S [7] and C693S
[12]) synthesized viral RNA more efﬁciently than wild-type ToMV
(Fig. 5I).
Effects of ToMV 130K protein cysteine-to-serine substitutions on pre-
membrane-targeting complex formation
The above results suggest that C179S, C186S, and C581S mutant
replication proteins are defective in membrane binding. Because
PMTC formation precedes membrane binding in the course of
replication complex formation, we examined whether C179S,
C186S, and C581S mutants can form the PMTC. Wild-type and
mutant ToMV RNAs were translated in mdBYL and fractionated by
sucrose gradient centrifugation under non-reducing conditions
(Fig. 6A). For wild-type ToMV, larger amounts of the replication
proteins were detected in fractions 1 and 3 than in the other
fractions, and the largest amount of the genomic RNA was found in
fraction 3 (Fig. 6B). Most of the wild-type ToMV replication proteins
in fraction 3 formed complexes that migrated slowly in non-reducing
SDS-PAGE and that disappeared after DTT treatment (Fig. 6B,
compare the –DTT panel with the þDTT panel). Note that the PMTC
that was formed in the presence of DTT and that contained
ToMV RNA and the replication proteins was fractionated in fraction
3 of the sucrose gradient (Komoda et al., 2007). In contrast,
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(B). ((G)–(I)) Effects of cysteine-to-serine mutations on the replication-related functions of ToMV replication proteins. Aliquots of the P15 membrane fractions were
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C581S mutants remained in fraction 1 (the loading layer), while the
genomic RNAs of these mutant ToMV were fractionated in fraction 3
(Fig. 6B). Consistently, FLAG-tagged wild-type 130K protein synthe-
sized in mdBYL co-immunoprecipitated the viral RNA, whereas
FLAG-tagged C179S, C186S, or C581S mutant 130K proteins didnot (Fig. 6C). These results indicate that the mutants cannot form
the PMTC.
Next, we examined whether the C179S, C186S, and C581S
mutant replication proteins are active in other functions. The
soluble form of ToMV replication proteins has the ability to bind
siRNA duplexes. This function contributes to the suppression of
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2007). To examine this activity, mutant replication proteins were
synthesized in mdBYL, and S100 fractions were prepared. Consistent
with the results shown in Fig. 5B, accumulated levels of C179S,
C186S, and C581S mutant replication proteins in the S100 fractions
(soluble replication proteins) were higher than those of the wild
type (Fig. 6D). Then the S100 fractions were incubated with a 32P-
labeled 22-nt RNA duplex and subjected to an electrophoretic
mobility shift assay. Mutant replication proteins bound the small
RNA duplex at similar or even higher efﬁciency compared to the
wild-type replication proteins (Fig. 6D).
Previously, we found that a ToMV RNA derivative that encodes
only a 130K protein and is unable to replicate by itself (TL130;
Fig. 6E) can replicate if soluble 180K protein is supplied in trans
(Komoda et al., 2007). To examine the effects of C179S, C186S, and
C581S mutations on this 180K protein activity, we translated
TL130 RNA (wild-type) in mdBYL, mixed with soluble 180K protein
carrying these mutations (the S100 fractions of mdBYL in which
TL180D30-type mRNAs (Fig. 6E) were translated). The reactions
were further incubated with BYL membranes and 32P-labeledribonucleoside triphosphates. TL130 RNA replicated (i.e., synthe-
sized the RF RNA) with the aid of the 180K proteins carrying the
C179S, C186S, and C581S mutations, as well as with the aid of wild-
type 180K protein (Fig. 6E). These results indicate that the C179S,
C186S, and C581S mutations speciﬁcally affect PMTC formation,
while retaining the ability to bind siRNA duplexes and support viral
RNA replication in trans.
Guanylylation-competent replication proteins of other positive-
strand RNA viruses are also in disulﬁde-linked complexes
Alignment of the amino acid sequences of the methyltransferase
domain of alpha-like viruses revealed that two cysteine residues
(C179 and C186 in ToMV) are conserved (Rozanov et al., 1992)
(Fig. 7A), and mutations in these residues result in the loss of viral
multiplication and/or capping-related functions [Alfalfa mosaic virus
1a (Vlot et al., 2002), BMV 1a (Yi and Kao, 2008), and Semliki forest
virus nsP1 (Ahola et al., 1997)]. Thus, we hypothesized that our
ﬁnding with ToMV might apply to other alpha-like viruses. To test
this possibility, we examined whether guanylylation-competent
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Fig. 7. Guanylylation-competent replication proteins of BMV and CMV are also contained in disulﬁde-linked, high-molecular-weight complexes. (A) Amino acid sequence
alignment for alpha-like virus replication protein regions corresponding to the 174th–191st residues of the ToMV 130K protein. ((B)–(D)) Analysis of guanylylation-
competent replication proteins. Extracts of tobacco BY-2 protoplasts inoculated with ToMV (B), CMV (C), and BMV (D) RNAs were fractionated by centrifugation at
15,000 g to obtain S15 and P15 fractions (indicated by S and P in the ﬁgure, respectively). The S15 and P15 fractions were incubated with [a-32P]GTP and AdoMet, and
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PAGE followed by immunoblotting with antibodies against each replication protein (lower panels).
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DTT-sensitive complexes. We inoculated tobacco BY-2 protoplasts
with BMV, CMV, and ToMV RNAs, prepared S15 and P15 fractions
from the extracts of the inoculated protoplasts without DTT, and then
incubated the fractions with [a-32P]GTP and AdoMet. The samples
were analyzed by reducing or non-reducing SDS-PAGE. In reducing
SDS-PAGE, infection-speciﬁc 32P-labeled bands were observed in P15
samples where BMV 1a, CMV 1a, or ToMV 130K proteins migrate
(100–130 kDa) (Fig. 7B to D). In contrast, in non-reducing SDS-PAGE,
the 32P-labeled bands were observed near the origin of gel electro-
phoresis (Fig. 7B to D). In protoplasts that were infected with ToMV
by electroporation, most of the soluble ToMV replication proteins
formed complexes that remained near the origin of non-reducing
SDS-PAGE (Fig. 7B). This was in contrast to experiments using plant
cells where ToMV infection was induced by estradiol (Fig. 1). This
may have been due to the oxidative status in plant cells induced
during preparation and the culture of protoplasts (Pineiro et al.,
1994). These results indicate that guanylylation-competent replica-
tion proteins of BMV and CMV are also in disulﬁde-linked complexes.Discussion
We found that a minor fraction of membrane-bound ToMV
replication proteins in estradiol-induced ToMV-infected cells
migrated in non-reducing SDS-PAGE near the origin of electro-
phoresis, and that guanylylation-competent replication proteins
were in this minor fraction (Fig. 1). After solubilization with a
detergent, guanylylation-competent replication proteins sedi-
mented through a sucrose gradient into the second fraction, while
most non-disulﬁde-linked ToMV replication proteins and 80S
ribosomes were fractionated to the ﬁrst (topmost) and third
fractions, respectively (Fig. 2) (Nishikiori et al., 2006). These
results suggest that guanylylation-competent ToMV replicationproteins are in intermolecularly disulﬁde-linked, high-molecular-
weight complexes. However, the composition and other details of
the complexes remain to be determined.
In eukaryotic cells, protein disulﬁde bonds are mostly formed
in the ER lumen or mitochondrial intermembrane space. These
locations provide an oxidizing environment. Cytosolic proteins
are rarely disulﬁde-linked (Riemer et al., 2009). Nevertheless, a
few cytosolic proteins do form intermolecular disulﬁde bonds
(Locker and Grifﬁths, 1999; Mou et al., 2003), and this study
provides an additional example.
To investigate the signiﬁcance of disulﬁde bond formation in
ToMV replication proteins in the activation of guanylylation activity,
we examined the phenotypes of ToMV mutants that carry the 130K
protein with cysteine-to-serine substitutions. Replication proteins
with C179S, C186S, or C581S substitutions exhibited pleiotropic
defects in forming the PMTC, binding to membranes, gaining
guanylyltransferase activity, and forming disulﬁde-linked complexes
(Fig. 5). In contrast, the 180K protein with C179S, C186S, or C581S
substitutions acquired RdRp activity when they were mixed with
membranes and the core PMTC that was formed by the ToMV
variant expressing only the 130K protein (Fig. 6). This suggests that
the 180K protein can be recruited to the replication complex through
molecular interactions that are not affected by these mutations.
Therefore, these mutations unlikely affect overall structure of the
replication proteins.
What is the direct consequence of C179S, C186S, and C581S
substitutions on ToMV replication proteins? The earliest step, i.e.,
PMTC formation should be directly affected by the mutations
(Fig. 6). PMTC is targeted to membrane surfaces to form the ToMV
replication complex (Komoda et al., 2007). Therefore, the inability
of the mutant replication proteins to bind to membranes would
be attributable in part to the inability of PMTC formation. On the
other hand, the replication proteins in the S100 fraction of wild-
type ToMV RNA-translated mdBYL showed guanylylation activity
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replication proteins can bind to membranes without PMTC for-
mation, and that the mutant replication proteins cannot bind to
membranes also via this pathway. It is known that cysteine
residues can be S-palmitoylated and this modiﬁcation can be
involved in membrane binding, however, the cysteine residues in
the 130K protein have not been predicted nor experimentally
shown to be S-palmitoylated. The lack of guanylylation activity
was likely due to the inability of the replication proteins to bind
to membranes because guanylylation activity in ToMV replication
proteins was only detected in the membrane fraction (Fig. 1), and
because the replication proteins synthesized in the absence of
membranes had little guanylylation activity unless mixed with
membranes (Fig. 3).
Considering that the ToMV PMTC and RNA replication complex
can form in DTT-containing BYL (Komoda et al., 2007, 2004),
disulﬁde bond formation itself is unlikely to be essential for PMTC
formation and membrane binding. Rather, we presume that PMTC
formation and membrane binding require non-covalent intermo-
lecular interactions involving cysteine residues in the replication
proteins. One possibility is that a sulfhydryl group of a cysteine
residue in a ToMV replication protein is placed in close vicinity to
that in another protein (perhaps another replication protein), and
they form disulﬁde bonds when the residues are placed in an
oxidizing environment, e.g., in a membrane-surrounded replica-
tion complex compartment or in vitro reaction mixtures without
DTT.
In yeast, the 130K replication protein expressed alone had some
membrane binding activity, but did not have guanylyltransferase
activity. It was also not efﬁciently disulﬁde-linked. In contrast, when
the 130K replication protein was co-expressed with TOM1 and ARL8
in yeast, it bound to membranes more efﬁciently, had guanylyl-
transferase activity, and was disulﬁde-linked (Fig. 4). Thus, one of
the roles of TOM1 and ARL8 in ToMV RNA replication might be to
provide the membrane-bound replication proteins with an oxidizing
environment, which leads to the formation of disulﬁde bonds and
activation of guanylyltransferase activity. Alternatively, TOM1 and
ARL8 may modify the conformation of the replication proteins to be
more suitable for disulﬁde bond formation and the enzymatic
activation. Under this hypothesis, because reduction of disulﬁde
bonds with DTT in solubilized ToMV replication proteins prepared
from the membranes of ToMV-infected plant cells did not affect
guanylylation activity (Fig. 2), once the replication proteins gain the
activity, disulﬁde bonds are no longer required for maintenance of
the activity.
The 179th and 186th cysteine residues in ToMV replication
proteins are conserved in the replication proteins of many alpha-
like positive-strand RNA viruses. For some viruses, they are
important for capping-related functions and replication (Ahola
et al., 2000, 1997; Rozanov et al., 1992). In this study, we found
that guanylylation-competent BMV and CMV 1a replication pro-
teins are also found in membrane-bound, disulﬁde-linked com-
plexes (Fig. 7). These results may highlight the evolutionary
conservation of common mechanisms for enzymatic activation
of replication proteins and importance of the replication protein
disulﬁde bonding in the replication of alpha-like viruses.
The BMV replication complexes consists of membranous invagi-
nations called spherules and/or multilayered membrane stacks
(Ahlquist, 2006; den Boon and Ahlquist, 2010; den Boon et al.,
2010). A spherule is 50–100 nm in diameter and each contains
approximately 200–400 1a proteins, 10–20 2a proteins, and a few
positive- and negative-strand RNA molecules (Schwartz et al., 2002).
The methyltransferase (capping) domain polypeptide of BMV 1a
forms extended, stacked, hexagonal lattices, possibly through multi-
ple intermolecular interactions. The helicase domain polypeptide
can also self-associate (Diaz et al., 2012). The formation of spherularBMV replication complexes depends on direct linkages and con-
certed action of the self-interacting methyltransferase and helicase
domains. Likewise, the helicase-like domain-containing fragments of
TMV 130K protein have the ability to self-interact and form ring-like
hexamers (Goregaoker and Culver, 2003; Goregaoker et al., 2001). In
ToMV, BMV, and CMV, intermolecular disulﬁde bonds may contri-
bute to the stabilization of such lattices. Further studies are required
to test this hypothesis.Materials and methods
Preparation of yeast and plant cell extracts
A transgenic Nicotiana tabacum BY-2 cell line RT4 was used, in
which infection with a ToMV derivative that encodes the 130K
and FLAG-StrepII-tagged 180K (180K-FS) proteins can be induced
by treatment with estradiol (Nishikiori et al., 2006) (Figs. 1, 2 and
4). A protease-deﬁcient yeast strain BJ5465 was used for the
expression of TOM1, ARL8, and FLAG-StrepII-tagged 130K protein
(130K-FS) (Nishikiori et al., 2011) (Fig. 4). Inoculation of tobacco
BY-2 protoplasts with viral RNA by electroporation was described
previously (Ishikawa et al., 1993; Watanabe et al., 1987) (Fig. 7). The
cell extracts of virus-infected evacuolated BY-2 protoplasts [iBYL
(Nishikiori et al., 2006)] and yeast spheroplasts were prepared as
described previously using a hypotonic buffer (10 mM Tris–HCl [pH
8], 10 mM EDTA with one tablet of Complete Mini protease inhibitor
[Roche] per 10 ml) (Nishikiori et al., 2011).
In vitro translation and replication
Mutations were introduced by the overlap PCR method into
pTLW3(Sma) (Komoda et al., 2007) to alter the sequences encoding
each of the 19 cysteine residues in ToMV 130K protein. Wild-type
and mutant RNAs were synthesized in vitro by an AmpliCap-Max T7
transcription kit (Cellscript). Evacuolated BY-2 protoplast extracts
(BYL) and membrane-depleted BYL (mdBYL) were prepared as
described previously (Komoda et al., 2007, 2004), except that DTT
was omitted from the TR buffer (30 mM Hepes-KOH [pH 7.4],
80 mM KOAc, 1.8 mM MgOAc, and one tablet of Complete protease
inhibitor per 10 ml). Wild-type and mutant ToMV RNAs (1.2 mg)
were translated in 60-ml reaction mixtures at 25 1C for 60 min.
Protein guanylylation and RdRp assays were performed as described
previously (Komoda et al., 2004; Nishikiori et al., 2011), except that
DTT and RNase inhibitor were omitted from the reaction mixtures.
SDS-PAGE and immunoblotting
SDS-PAGE was performed using NuPAGE 3–8% Tris–acetate gels
(Invitrogen). Protein samples for SDS-PAGE were treated with
N-ethylmaleimide (ﬁnal 12.5 mM) at 4 1C for 10 min to avoid
disulﬁde bond exchange reactions upon denaturation (Kono et al.,
1998), precipitated with 10% trichloroacetic acid, and dissolved in
standard sample buffer with (ﬁnal 100mM) or without DTT. After
SDS-PAGE, the gels were soaked in a DTT-containing transfer buffer
(25 mM Tris, 190 mM glycine, 10 mM DTT) for 10 min at room
temperature to facilitate electrotransfer of proteins in disulﬁde-linked
complexes to the PVDF membrane. Antibodies against ToMV 130K
and 180K, BMV 1a, and CMV 1a proteins were described previously
(Hagiwara et al., 2003; Restrepo-Hartwig and Ahlquist, 1996; Yoshii
et al., 2004).
Sucrose gradient sedimentation analysis
Sucrose gradient sedimentation analysis in Fig. 2 was performed
as described previously (Nishikiori et al., 2006), except that GTP was
M. Nishikiori et al. / Virology 434 (2012) 118–128 127omitted from solutions used for sample solubilization and fractiona-
tion. Brieﬂy, P15 membranes from 67 ml iBYL were incubated at
15 1C for 20 min in 200 ml of NTR buffer (30 mM Hepes-KOH [pH
7.4], 80 mM KOAc, 1.8 mM MgOAc, 0.2 mM ATP and UTP, and one
tablet of Complete mini protease inhibitor per 10 ml) containing 1%
(wt/vol) lysophosphatidylcholine (LPC) with or without DTT (2 mM).
The treated samples were loaded onto sucrose gradients (10–50%
[wt/wt]) and subjected to centrifugation (100,000 g for 1 h at 4 1C)
in a Beckman TLS-55 rotor. After centrifugation, the gradients were
manually fractionated into eight fractions of 300 ml of each. Sucrose
gradient sedimentation analysis in Fig. 6 was performed as described
previously (Komoda et al., 2007), except that DTT and RNase inhibitor
were omitted from the BYL translation mixtures and sucrose gradi-
ent. Brieﬂy, ToMV or mutant RNA (4 mg)-translated mdBYL reaction
mixtures (200 ml) were loaded onto sucrose gradients (15–40% [wt/
vol]) and subjected to centrifugation (100,000 g for 2 h at 4 1C) in a
Beckman TLS-55 rotor. After centrifugation, the gradients were
manually fractionated into ﬁve fractions.
Immunoprecipitation of ToMV replication proteins
The ToMV 130K-FS protein was immunoprecipitated from
mdBYL-based reaction mixtures (500 ml in Fig. 3 and 150 ml in
Fig. 6) as described previously (Komoda et al., 2007). Immuno-
precipitation of 130K-FS and 180K-FS proteins from the extracts
of yeast and plant cells was performed as described previously
(Nishikiori et al., 2006, 2011), expect that DTT and GTP were
omitted from solubilization buffer (30 mM Hepes-KOH [pH 7.4],
80 mM KOAc, 1.8 mM MgOAc, 0.2 mM ATP and UTP, 1% LPC, and
one tablet of Complete mini protease inhibitor per 10 ml).
Small RNA duplex binding assay
The binding of ToMV replication proteins to a 22-nt RNA
duplex was examined as described previously (Iki et al., 2010;
Ishibashi et al., 2011).Acknowledgments
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